Physiology and pathophysiology of matrix metalloproteases.

Amino Acids
T Klein, R Bischoff

Abstract

Matrix metalloproteases (MMPs) comprise a family of enzymes that cleave protein substrates based on a conserved mechanism involving activation of an active site-bound water molecule by a Zn(2+) ion. Although the catalytic domain of MMPs is structurally highly similar, there are many differences with respect to substrate specificity, cellular and tissue localization, membrane binding and regulation that make this a very versatile family of enzymes with a multitude of physiological functions, many of which are still not fully understood. Essentially, all members of the MMP family have been linked to disease development, notably to cancer metastasis, chronic inflammation and the ensuing tissue damage as well as to neurological disorders. This has stimulated a flurry of studies into MMP inhibitors as therapeutic agents, as well as into measuring MMP levels as diagnostic or prognostic markers. As with most protein families, deciphering the function(s) of MMPs is difficult, as they can modify many proteins. Which of these reactions are physiologically or pathophysiologically relevant is often not clear, although studies on knockout animals, human genetic and epigenetic, as well as biochemical studies using natural or synthetic inhibi...Continue Reading

References

Dec 1, 1990·Cancer Metastasis Reviews·S McDonnell, L M Matrisian
Jul 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·H E Van Wart, H Birkedal-Hansen
Jul 1, 1988·The Biochemical Journal·D MullerR Breathnach
Jul 25, 1986·Nucleic Acids Research·K NakahamaH Matsubara
Jan 1, 1987·The Biochemical Journal·P E ButlerJ S Bond
Dec 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·L M MatrisianR Breathnach
Dec 29, 1974·Biochimica Et Biophysica Acta·I Sopata, A M Dancewicz
Apr 1, 1983·The Journal of Experimental Medicine·M J BandaZ Werb
Oct 1, 1980·The Journal of Clinical Investigation·R M SeniorR P Mecham
Jun 1, 1995·Current Opinion in Structural Biology·W Stöcker, W Bode
May 23, 1995·Biochemistry·M F BrownerA L Castelhano
Jul 1, 1994·The Journal of Clinical Investigation·U K Saarialho-KereH G Welgus
Aug 1, 1994·Arthritis and Rheumatism·M P VincentiC E Brinckerhoff
May 1, 1993·The Biochemical Journal·V KnäuperH Tschesche
Dec 1, 1995·Annals of the Rheumatic Diseases·S MaedaM Sakurai
Jan 19, 1996·The Journal of Biological Chemistry·V KnäuperG Murphy
Apr 30, 1996·Proceedings of the National Academy of Sciences of the United States of America·J M ShipleyS D Shapiro
Jul 9, 1996·Proceedings of the National Academy of Sciences of the United States of America·E LeviI Vlodavsky
Feb 1, 1996·The International Journal of Biochemistry & Cell Biology·C L Wilson, L M Matrisian
Jan 1, 1996·Enzyme & Protein·J F Wiesen, Z Werb
Nov 12, 1996·Biochemical and Biophysical Research Communications·S ChandlerG Wells
Apr 17, 1997·Nature·W Risau
Mar 1, 1997·Matrix Biology : Journal of the International Society for Matrix Biology·G Murphy, V Knäuper
Jul 1, 1997·American Journal of Respiratory and Critical Care Medicine·G A FinlayC M O'Connor
Aug 7, 1997·International Journal of Cancer. Journal International Du Cancer·B NawrockiP Birembaut

❮ Previous
Next ❯

Citations

May 20, 2011·Amino Acids·Hartmut Schlüter, Peter R Jungblut
Jun 13, 2012·Molecular and Cellular Biology·Amanda BeauchampWaldemar Debinski
Jul 14, 2012·Journal of Parasitology Research·Carolina Piña-VázquezJesús Serrano-Luna
Jan 24, 2013·PloS One·Ya-qing LiXiao-jun Huang
Jun 7, 2013·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Tiffany L SudduthDonna M Wilcock
Apr 27, 2012·American Journal of Veterinary Research·Andreia A SantosAugusto J F de Matos
Jan 2, 2014·Journal of Cardiovascular Translational Research·Reid G HendryDavid J Marchant
Aug 6, 2013·Cellular and Molecular Life Sciences : CMLS·Charles A GaleaRaymond S Norton
Feb 1, 2013·TheScientificWorldJournal·Suvi-Tuuli VilenPia Nyberg
Oct 22, 2013·Molecular and Cellular Neurosciences·Mieke VerslegersLieve Moons
Jan 16, 2014·Pathology Oncology Research : POR·Noor Al-DasooqiRachel J Gibson
Aug 2, 2014·The Journal of Clinical Investigation·Eun Myoung ShinVinay Tergaonkar
May 28, 2014·International Journal of Surgery·Stefano de FranciscisRaffaele Serra
Feb 8, 2013·Inflammation·Sabrina LisiDomenico Ribatti
Jul 31, 2013·Biochemical and Biophysical Research Communications·Julia M SantosRenu A Kowluru
Nov 16, 2014·BMC Complementary and Alternative Medicine·Ding-Qian WuLi Ba
Apr 14, 2015·Periodontology 2000·Matthias ChiquetDimitris Kletsas
Dec 21, 2012·Expert Opinion on Therapeutic Targets·Ming-Hsien ChienShun-Fa Yang
Oct 31, 2014·International Journal of Molecular Sciences·Fabio CattaneoRosario Ammendola
Apr 24, 2012·Expert Opinion on Investigational Drugs·Renu A KowluruJulia M Santos
Sep 19, 2015·Biochimie·Sylvie Ricard-Blum, Sylvain D Vallet
Feb 4, 2016·BMC Veterinary Research·Manuela MartanoPaola Maiolino
Jan 19, 2016·Matrix Biology : Journal of the International Society for Matrix Biology·H XuB L Foster
Jul 1, 2015·Archivum Immunologiae Et Therapiae Experimentalis·Katarzyna GrzelaTomasz Grzela
Oct 1, 2011·The Journal of Thoracic and Cardiovascular Surgery·Veronica JacksonPer Eriksson
Sep 29, 2011·Drug Discovery Today·Wenni Tong, Lubo Zhang
Nov 26, 2015·Journal of Alzheimer's Disease : JAD·Erica M Weekman, Donna M Wilcock
Jan 31, 2013·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Tiffany L SudduthDonna M Wilcock

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic
glycosylation
xenograft
lavage

Related Concepts

Related Feeds

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.